These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 34915408)
1. Impact of COVID-19 and suspension of colorectal cancer screening on incidence and stage distribution of colorectal cancers in the Netherlands. Toes-Zoutendijk E; Vink G; Nagtegaal ID; Spaander MCW; Dekker E; van Leerdam ME; Siesling S; Lansdorp-Vogelaar I; Elferink MAG; Eur J Cancer; 2022 Jan; 161():38-43. PubMed ID: 34915408 [TBL] [Abstract][Full Text] [Related]
2. Colorectal cancer incidence, mortality, tumour characteristics, and treatment before and after introduction of the faecal immunochemical testing-based screening programme in the Netherlands: a population-based study. Breekveldt ECH; Lansdorp-Vogelaar I; Toes-Zoutendijk E; Spaander MCW; van Vuuren AJ; van Kemenade FJ; Ramakers CRB; Dekker E; Nagtegaal ID; Krul MF; Kok NFM; Kuhlmann KFD; Vink GR; van Leerdam ME; Elferink MAG; Lancet Gastroenterol Hepatol; 2022 Jan; 7(1):60-68. PubMed ID: 34822762 [TBL] [Abstract][Full Text] [Related]
3. The impact of the temporary suspension of national cancer screening programmes due to the COVID-19 epidemic on the diagnosis of breast and colorectal cancer in the Netherlands. Dinmohamed AG; Cellamare M; Visser O; de Munck L; Elferink MAG; Westenend PJ; Wesseling J; Broeders MJM; Kuipers EJ; Merkx MAW; Nagtegaal ID; Siesling S J Hematol Oncol; 2020 Nov; 13(1):147. PubMed ID: 33148289 [TBL] [Abstract][Full Text] [Related]
4. Impact of SARS-CoV-2 Pandemic on Colorectal Cancer Screening Delay: Effect on Stage Shift and Increased Mortality. Ricciardiello L; Ferrari C; Cameletti M; Gaianill F; Buttitta F; Bazzoli F; Luigi de'Angelis G; Malesci A; Laghi L Clin Gastroenterol Hepatol; 2021 Jul; 19(7):1410-1417.e9. PubMed ID: 32898707 [TBL] [Abstract][Full Text] [Related]
5. Impact of the COVID-19 pandemic on faecal immunochemical test-based colorectal cancer screening programmes in Australia, Canada, and the Netherlands: a comparative modelling study. de Jonge L; Worthington J; van Wifferen F; Iragorri N; Peterse EFP; Lew JB; Greuter MJE; Smith HA; Feletto E; Yong JHE; Canfell K; Coupé VMH; Lansdorp-Vogelaar I; Lancet Gastroenterol Hepatol; 2021 Apr; 6(4):304-314. PubMed ID: 33548185 [TBL] [Abstract][Full Text] [Related]
6. The national FIT-based colorectal cancer screening program in the Netherlands during the COVID-19 pandemic. Kortlever TL; de Jonge L; Wisse PHA; Seriese I; Otto-Terlouw P; van Leerdam ME; Spaander MCW; Dekker E; Lansdorp-Vogelaar I Prev Med; 2021 Oct; 151():106643. PubMed ID: 34217421 [TBL] [Abstract][Full Text] [Related]
7. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing. van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499 [TBL] [Abstract][Full Text] [Related]
8. Initial Impact of National CRC Screening on Incidence and Advanced Colorectal Cancer. Krul MF; Elferink MAG; Kok NFM; Dekker E; Lansdorp-Vogelaar I; Meijer GA; Nagtegaal ID; Breekveldt ECH; Ruers TJM; van Leerdam ME; Kuhlmann KFD Clin Gastroenterol Hepatol; 2023 Mar; 21(3):797-807.e3. PubMed ID: 36116753 [TBL] [Abstract][Full Text] [Related]
9. Effect of the SARS-CoV-2 pandemic on colorectal cancer diagnosis and prognosis. Medina-Prado L; Sala-Miquel N; Aicart-Ramos M; López-Cardona J; Ponce-Romero M; Ortíz O; Pellisé M; Aguilera L; Díez-Redondo P; Núñez-Rodríguez H; Seoane A; Domper-Arnal MJ; Borao-Laguna C; González-Bernardo Ó; Suárez A; Muñoz-Tornero M; Bustamante-Balén M; Soutullo-Castiñeiras C; Balleste-Peris B; Esteban P; Jiménez-Gómez M; Albert M; Lucas J; Valdivieso-Cortázar E; López-Serrano A; Solano M; Tejedor-Tejada J; Trelles M; Zapater P; Jover R Cancer Med; 2024 Mar; 13(5):e6923. PubMed ID: 38491824 [TBL] [Abstract][Full Text] [Related]
10. Impact of the COVID-19 pandemic on the in-hospital diagnostic pathway of breast and colorectal cancer in the Netherlands: A population-based study. Wolfkamp W; Meijer J; van Hoeve JC; van Erning F; de Geus-Oei LF; de Hingh I; Veltman J; Siesling S; Cancer Med; 2024 Jan; 13(1):e6861. PubMed ID: 38197670 [TBL] [Abstract][Full Text] [Related]
11. Advanced-stage CRC incidence patterns following the phased implementation of the CRC screening programme in the Netherlands. Breekveldt ECH; Toes-Zoutendijk E; Spaander MCW; van de Schootbrugge-Vandermeer HJ; van Vuuren AJ; van Kemenade FJ; Ramakers CRB; Dekker E; Nagtegaal ID; van Leerdam ME; Lansdorp-Vogelaar I Eur J Cancer; 2023 Jan; 178():60-67. PubMed ID: 36403368 [TBL] [Abstract][Full Text] [Related]
12. A Final Report on the Real Impact of the COVID-19 Pandemic on the Diagnosis of Gastrointestinal Cancer in Akita Prefecture, Japan in 2022. Iijima K; Watanabe K; Shimodaira Y; Koizumi S; Fukuda S; Yoshida T; Ookubo R; Matsuhashi T; Jin M; Miura M; Shibata H Tohoku J Exp Med; 2024 Jul; 263(2):161-168. PubMed ID: 38658347 [TBL] [Abstract][Full Text] [Related]
13. Impact of the COVID-19 pandemic on breast cancer incidence and tumor stage in the Netherlands and Norway: A population-based study. Eijkelboom AH; de Munck L; Larsen M; Bijlsma MJ; Tjan-Heijnen VCG; van Gils CH; Broeders MJM; Nygård JF; Lobbes MBI; Helsper CW; Pijnappel RM; Strobbe LJA; Wesseling J; Hofvind S; Siesling S; Cancer Epidemiol; 2023 Dec; 87():102481. PubMed ID: 37897970 [TBL] [Abstract][Full Text] [Related]
14. Short-term impact of the COVID-19 pandemic on a population-based screening program for colorectal cancer in Catalonia (Spain). Vives N; Binefa G; Vidal C; Milà N; Muñoz R; Guardiola V; Rial O; Garcia M Prev Med; 2022 Feb; 155():106929. PubMed ID: 34954239 [TBL] [Abstract][Full Text] [Related]
15. Trends in the Stage Distribution of Colorectal Cancer During the COVID-19 Pandemic in Japan: A Nationwide Hospital-claims Data Analysis. Ota M; Taniguchi K; Asakuma M; Lee SW; Ito Y J Epidemiol; 2024 Jul; 34(7):356-361. PubMed ID: 38044088 [TBL] [Abstract][Full Text] [Related]
16. Limited impact of the COVID-19 pandemic on colorectal cancer care in the Netherlands in 2020. Meijer J; Elferink MAG; Vink GR; Sijtsma FPC; Buijsen J; Nagtegaal ID; Tanis PJ; Wumkes ML; de Hingh IHJT; Siesling S; Int J Colorectal Dis; 2022 Sep; 37(9):2013-2020. PubMed ID: 35986108 [TBL] [Abstract][Full Text] [Related]
17. Delayed Colorectal Cancer Diagnosis during the COVID-19 Pandemic in Alberta: A Framework for Analyzing Barriers to Diagnosis and Generating Evidence to Support Health System Changes Aimed at Reducing Time to Diagnosis. Walker E; Fu Y; Sadowski DC; Stewart D; Tang P; Kaposhi B; Chappell H; Robson P; Veldhuyzen van Zanten S Int J Environ Res Public Health; 2021 Aug; 18(17):. PubMed ID: 34501687 [TBL] [Abstract][Full Text] [Related]
18. Gastrointestinal Cancer Stage at Diagnosis Before and During the COVID-19 Pandemic in Japan. Kuzuu K; Misawa N; Ashikari K; Kessoku T; Kato S; Hosono K; Yoneda M; Nonaka T; Matsushima S; Komatsu T; Nakajima A; Higurashi T JAMA Netw Open; 2021 Sep; 4(9):e2126334. PubMed ID: 34546368 [TBL] [Abstract][Full Text] [Related]
19. Effectiveness of Colorectal Cancer Screening in Detecting Earlier-Stage Disease-A Nationwide Cohort Study in Denmark. Larsen MB; Njor S; Ingeholm P; Andersen B Gastroenterology; 2018 Jul; 155(1):99-106. PubMed ID: 29626451 [TBL] [Abstract][Full Text] [Related]
20. The real-word impact of breast and colorectal cancer surgery during the SARS-CoV-2 pandemic. Losurdo P; Samardzic N; Di Lenarda F; de Manzini N; Giudici F; Bortul M Updates Surg; 2022 Jun; 74(3):1063-1072. PubMed ID: 34978052 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]